Rebecca Redman

Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database

Jordi Rello, Daniel A. Ollendorf, Gerry Oster et al. · CHEST Journal · 2002 · 1.3K citations

Epidemiology, Respiratory Diseases, Clinical Epidemiology +9

Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study

Kenji Tamura, Junji Tsurutani, Shunji Takahashi et al. · The Lancet Oncology · 2019 · 343 citations

Breast Oncology, Oncology, Breast Cancer +6

Targeting 6-Phosphofructo-2-Kinase (PFKFB3) as a Therapeutic Strategy against Cancer

Brian F. Clem, Julie O’Neal, Gilles Tapolsky et al. · Molecular Cancer Therapeutics · 2013 · 272 citations · Full text

Tumor Biology, Biochemistry, Medicine +13

Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial

Christophe Hézode, Tarik Asselah, K. Rajender Reddy et al. · The Lancet · 2015 · 257 citations

Open-label Trial, Hepatology, Hepatitis C +11

A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia

Marin H. Kollef, Jean Chastre, M. Clavel et al. · Critical Care · 2012 · 211 citations · Full text